Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Income (Unaudited)

v3.25.3
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 1,273.7 $ 1,240.3 $ 3,754.5 $ 3,785.7
Cost of sales [1],[2] 284.2 268.7 826.3 836.8
Gross profit 989.5 971.6 2,928.2 2,948.9
Royalty overrides 416.1 405.5 1,224.4 1,236.0
Selling, general, and administrative expenses 447.6 444.0 1,327.4 1,438.5
Other operating income 0.0 (5.0) (4.8) (5.0)
Operating income 125.8 127.1 381.2 279.4
Interest expense, net 51.0 56.5 156.6 152.1
Other expense, net 0.0 0.0 0.0 10.5
Income before income taxes 74.8 70.6 224.6 116.8
Income taxes 31.7 23.2 81.9 40.4
Net income 43.1 47.4 142.7 76.4
Net loss attributable to noncontrolling interest (0.1) 0.0 (0.2) 0.0
Net income attributable to Herbalife $ 43.2 $ 47.4 $ 142.9 $ 76.4
Earnings per share attributable to Herbalife:        
Basic $ 0.42 $ 0.47 $ 1.39 $ 0.76
Diluted $ 0.42 $ 0.46 $ 1.38 $ 0.75
Weighted-average shares outstanding:        
Basic 103.3 100.9 102.6 100.4
Diluted 104.0 101.9 103.2 101.4
[1] As a result of adopting ASU 2023-07 during the fourth quarter of 2024, the Company has expanded and updated its disclosures for the current year and prior year periods as described in Note 2, Basis of Presentation, to the Consolidated Financial Statements included in the 2024 10-K.
[2] The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.